Hengrui Medicine Co., Ltd., commonly known as Hengrui Pharma, is a leading biopharmaceutical company headquartered in China (CN). Founded in 1993, Hengrui has established a strong presence in the global pharmaceutical industry, focusing on innovative drug development, manufacturing, and marketing. The company operates extensively across Asia, Europe, and North America, positioning itself as a key player in oncology, anaesthesia, and imaging agents. Hengrui Pharma is renowned for its commitment to research and development, with a diverse portfolio that includes targeted therapies and biologics. Its unique approach to drug formulation and delivery has garnered recognition, contributing to its market leadership. With numerous accolades and a robust pipeline of products, Hengrui continues to advance healthcare solutions, making significant strides in improving patient outcomes worldwide.
How does Hengrui Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hengrui Pharma's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hengrui Pharma, headquartered in China (CN), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate commitments, often aligning with global initiatives to reduce greenhouse gas emissions. Hengrui Pharma's approach to climate action remains unclear, but the industry trend suggests a growing emphasis on environmental responsibility and carbon footprint reduction.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hengrui Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.